VCEL
Vericel Corporation
NASDAQ · USHealthcareBiotechnology
$45.88-1.63%
Price as of Jul 20, 2026
VCEL capital
Vericel Corporation capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.27x
- Net debt / equity
- -0.04x
- Debt / assets
- 0.19x
- Debt / EBITDA
- 2.68x
- Net debt / EBITDA
- -0.42x
Liquidity & coverage
- Current ratio
- 5.18x
- Quick ratio
- 4.79x
- Cash ratio
- 3.08x
- Interest coverage
- 24.76x
- EBITDA / interest
- 55.35x
- Working capital
- $196.9M
Cash & dividend
- FCF / debt
- 0.61x
- Cash flow / debt
- 0.65x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.